Dana dhuwit perusahaan: kinetabio.com (KA)

Logo perusahaan publik Kineta Bio (KA)

Kineta, Inc. (KA) is developing advanced methods to combat resistant solid tumors, targeting the expansive precision oncology market. Changes in cash and cash equivalents demonstrate the issuer's liquidity, with the 0.00 level serving as a critical benchmark. Management is currently seeking ways to capitalize on existing developments following a hiatus in research. The company aims to confirm the efficacy of drugs that suppress immunosuppression within neoplasms.

KA - Volume dana dhuwit perusahaan Kineta Bio ing rentang 28.04.2023 - 28.09.2024

Ringkesan rincian data analitis Kineta Inc (KA)

- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:kinetabio.com
Sampel barang Kineta

Shifting antibody production to the contract facilities of Kineta, Inc. (KA) shifts the control focus toward liquidity management. This metric measures the volume of available cash, determining the company's ability to fund R&D without incurring external debt. Stable reserves prevent cash flow gaps, although excess funds may signal low investment efficiency. By analyzing the cash balance, an investor assesses the financial stability of the business.

Pesaing utama

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|LYEL: Total volume dana dhuwit perusahaan|Innate Pharma SA - Dhuwit awis perusahaan|Pyxis Oncology, Inc. (PYXS) - Cadangan dhuwit perusahaan|Compugen - Volume dana dhuwit perusahaan|Aset likuid perusahaan IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Dhuwit awis perusahaan|INKT - Aset likuid perusahaan|Dana dhuwit perusahaan werewolftx.com|Dhuwit awis perusahaan Immix Biopharma, Inc. (IMMX)|Dhuwit awis perusahaan ALXO (ALX Oncology Holdings)|Dana dhuwit perusahaan CUE (Cue Biopharma)|Volume dana dhuwit perusahaan PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Cadangan dhuwit perusahaan|MAIA Biotechnology - Volume dana dhuwit perusahaan|LIMN - Volume dana dhuwit perusahaan|LVTX: Volume dana dhuwit perusahaan|NextCure - Sisa dhuwit perusahaan|LPTX (Leap Therapeutics Inc) - Volume dana dhuwit perusahaan|INTS (Intensity Therapeutics, Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan SNSE|Dana dhuwit perusahaan TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Dhuwit awis perusahaan|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan